Stay updated on Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new study location in Illinois was added and the footer revision updated to v3.3.3; the HHS Vulnerability Disclosure entry was removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:21:09.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Publication notes now state that PubMed publications are auto-filled, and the old PubMed wording was removed; the page revision has been updated to v3.3.2, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T18:49:14.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The NIH operating-status notice has been removed from the page. All study details, eligibility criteria, and related content appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:59:48.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the page content and layout remain focused on the study overview, eligibility criteria, and contacts.
    Difference
    0.4%
    Check dated 2025-11-03T12:48:58.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-05T17:34:56.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T11:15:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.